Psilocybin Prevents Chemotherapy-Related Nerve Injury and Associated Symptoms in Preclinical Models
Researchers found two doses of psilocybin before chemotherapy preserved nerve function in mice and kept tumor-killing effects intact, the study said.
6 Articles
6 Articles
Writing Science, 3 Sep (EFE).- Psilocybin is a naturally occurring psychedelic compound that could help prevent one of the most debilitating side effects of chemotherapy, without reducing its antitumor effects, according to a study in mice. Peripheral chemotherapy-induced neuropathy (IPN) is a frequent consequence (affects more [...] The entry Psilocybin prevents, in mice, a side effect of chemotherapy was first published in HolaNews.
Deafness, pain, aborted cancer therapies: nerve damage is one of the most severe side effects of chemotherapy. The drug psilocybin reliably prevents at least mice, find out US researchers. Clinical studies in humans should follow soon.
Psilocybin prevents chemotherapy-related nerve injury and associated symptoms in preclinical models
In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated treatment cycles. The findings could help prevent pain, numbness and other common chemotherapy side effects.
Neuropathy affects many people during chemotherapy. So far, no drug can prevent nerve damage. Why, of all people, psilocybin could help.
Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice
A study found that psilocybin given before chemotherapy prevented the onset of nerve injury in mouse models, even after repeated treatment cycles, and also protected tumor-bearing mice from neuropathy, without impairing antitumor efficacy. The post Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice appeared first on GEN - Genetic Engineering and Biotechnology News.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
